BioStem Technologies, Inc.
BSEM
$3.85
-$0.11-2.68%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 235.65M | 243.59M | 300.15M | 275.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 235.65M | 243.59M | 300.15M | 275.89M |
| Cost of Revenue | -- | 6.28M | 9.31M | 9.31M | 12.37M |
| Gross Profit | -- | 229.38M | 234.28M | 290.84M | 263.52M |
| SG&A Expenses | -- | 206.97M | 205.50M | 262.07M | 227.92M |
| Depreciation & Amortization | -- | 234.80K | 231.20K | 231.20K | 223.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 220.36M | 220.46M | 277.02M | 244.05M |
| Operating Income | -- | 15.29M | 23.14M | 23.14M | 31.84M |
| Income Before Tax | -- | 15.35M | 23.03M | 23.03M | 31.45M |
| Income Tax Expenses | -- | -4.28M | -2.65M | -3.23M | -1.08M |
| Earnings from Continuing Operations | -- | 19.63 | 25.68 | 26.26 | 32.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 19.63M | 25.68M | 26.26M | 32.53M |
| EBIT | -- | 15.29M | 23.14M | 23.14M | 31.84M |
| EBITDA | -- | 6.98M | 14.82M | 14.82M | 23.52M |
| EPS Basic | -- | 1.18 | 1.56 | 1.59 | 1.98 |
| Normalized Basic EPS | -- | 0.26 | 0.56 | 0.56 | 0.88 |
| EPS Diluted | -- | 0.78 | 1.07 | 1.09 | 1.39 |
| Normalized Diluted EPS | -- | 0.17 | 0.40 | 0.40 | 0.64 |
| Average Basic Shares Outstanding | -- | 66.67M | 66.24M | 66.24M | 65.83M |
| Average Diluted Shares Outstanding | -- | 90.68M | 88.58M | 88.58M | 93.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |